Fundraising Fox

Jengu Therapeutics, Inc.

San Diego, US · Founded 2020 · Delaware corporation · 1 known investors

Biotech

Founders & leadership

EF
ERIC FISCHERNamed on SEC filing

Board

COCLARE OZAWA
CLARE OZAWAinBoard directorManaging Director at Versant Ventures
TWTHOMAS WOIWODE
THOMAS WOIWODEinBoard directorManaging Director at Versant Ventures
JCJEREMY CALDWELL
JEREMY CALDWELL𝕏Board directorVenture Partner at Versant Ventures

Investors · 1

Versant VenturesreportedSan Francisco · $250K – $5Mvia Clare Ozawa · board

Reported raises · per SEC filings

Form D private placements

$5M disclosed across 1 round · 2020

▶$5MraisedSep 2020 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • CLARE OZAWADirector
  • THOMAS WOIWODEDirector
  • JEREMY CALDWELLExecutive Officer, Director
  • ERIC FISCHERDirector
Offering amount
$50M
Amount sold
$5M
Minimum investment
$1
First sale
Sep 2020
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are Jengu Therapeutics, Inc.'s investors?
Jengu Therapeutics, Inc.'s investors include Versant Ventures.
How much funding has Jengu Therapeutics, Inc. raised?
Jengu Therapeutics, Inc. has disclosed $5M raised across 1 round.
Where is Jengu Therapeutics, Inc. headquartered?
Jengu Therapeutics, Inc. is headquartered in San Diego, US.